Clinical Case Database / Category: Patient Management

Post-transplant lymphoproliferative disease

Publication details

Dr Issaam Oozeerally, Dr Jonathan Barratt
Foundation Years Journal, volume 9, issue 5, p.38 (123Doc Education, London, May 2015)

Abstract

Organ transplantation is one of the pillars of modern medicine. The increasing success of organ transplantation means the chances of Foundation doctors encountering a patient with a transplant on the acute medical or surgical take have never been higher. The immunosuppression used in transplantation increases the risk of developing a wide range of infectious complications. Post-transplant lymphoproliferative disorder (PTLD) is an important post-transplant complication that Foundation doctors should be aware of. In the vast majority of cases PTLD is caused by the Epstein-Barr Virus (EBV). We present a case of EBV-driven PTLD complicating renal transplantation followed by a brief overview of PTLD.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

Dr Issaam Oozeerally

John Walls Renal Unit
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW
issaam.oozeerally@uhl-tr.nhs.uk

Dr Jonathan Barratt (Corresponding author)

John Walls Renal Unit
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW
jonathan.barratt@uhl-uhl.nhs.uk

References

1. Gonzalez-Cuyas, LF., Tavora, F., Burke, AP., Gocke, CD., Zimrin, A., Sauk, JJ., Zhao, XF., Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and view of the literature Diagnostic Pathology 2007; 2: 49-55
2. Cader, RA.,Mohd, R., Gafor, HA., Kong, NCT., Post Transplant Lymphoproliferative Disorder: A case series and review of literature EXCLI Journal 2013; 12: 144-149
3. Parker, A., Bowles, K., Bradley, JA., Emery, V., Featherstone, C., Gupte, G., Marcus, R., Parameshwar, J., Ramsay, A., Newstead, C., Writing Group: On behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society Diagnosis of post-transplant lymphoproliferatve disorder in solid organ transplant recipients - BCSH and BTS Guidelines British Journal Of Haematology, 149: 675-692
4. Morton DM., Epstein-Barr Virus in Adult Renal Transplant Recipients A Thesis Submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Medical and Human Sciences; 2013
5. Karuthu, S., Blumberg, EA, Common Infections in Kidney Transplant Recipients Clin J Am Soc Nephrol 2012; 7: 2058-2070
6. Franco, A., Jimenez, L., Sillero, C., Trigueros, M., Gonzalez, D., Alcaraz, E., Olivares, J., Post-Transplant lymphoproliferative disorders in renal transplantation: two decades of experience Nefrologia 2010; 30(6): 669-75
7. Kruel, CR., Ruiz, RM., Shiller, SM., Anthony, TL., Goldstein, RM., Kim, PTW, Levy, MF., Mckenna, GJ., Onaca, N., Testa, G., Klintmalm, GB., Posttransplant lymphoproliferative disorder presenting as a small bowel obstruction in a patient with pancreas transplantation alone Proc (BaylUniv Med Cent) 2014; 27(4): 346-348
8. Green, M., Management of Epstein-Barr Virus-induced Post-transplant lymphoproliferative disease in recipients of solid organ transplantation American Journal of Transplantation 2001; 1: 103-108
9. Morscio, J., Dierickx, D., Tousseyn, T., Molecular Pathogenesis of B-cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far? Clin Dev Immunol. 2013;2013:150835. doi: 10. 1155/2013/150835
10 Gulley, ML, Tang, W., Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder Clinical Microbiology Reviews April 2010 Vol 23 350-366
11. Heslop, HE., How I treat EBV lymphoproliferation Blood 2009 114: 4002-4008
12. Weikert, BC., Blumberg, EA., Viral infection after Renal Transplantation: Surveillance and Management Clin J Am Soc Nephrol 2008; 3: 576-586
13. Grywalska, E., Markowicz, J., Grabarczyk, P., Paslarski, M., Rolinski, J., Epstein-Barr virus-associated lymphoproliferative disorders PostepyHig Med Dosw (online), 2013; 76: 481- 490
14. Neparidze, N., Lacy, J., Malignancies Associated with Epstein-Barr Virus: Pathobiology, Clinical Features, and Evolving Treatments Clinical Advances in Haematology and Oncology 2014 12; 6: 358 - 371
15. Newstead, CG.,Lymphoproliferative disease post-renal transplantation Nephrol Dial Transplant (2000) 15: 1913-1916
16 Karras, A., Thervet, E., Le Meur, Y., Baudet-Bonneville, V., Kessler, M., Legendre, C., Successful Renal Retransplantation After Post-Transplant Lymphoproliferative Disease American Journal Of Transplantation 2004; 4: 1904 -1909
17. Carbone, A., Gloghini, A., Dotti, G., EBV-Associate Lymphoproliferative Disorders: Classification and Treatment The Oncologist 2008; 13: 577 - 585
18. Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the care of Kidney Transplant Recipients American Journal of Transplantation 2009' 9 (Suppl 3): Si-Si
19. Flanagan, KH., Brennan, DC., EBV-associated recurrent Hodgkin's disease after renal transplantation European Society for Organ Transplantation 19 (2006) 338- 341
20. Trofe, J., Buell, JF., Beebe, TM., Hanaway, MJ., First, MR., Alloway, RR., Gross, TG., Succop, P., Woodle ES., Analysis of Factors that Influence Survival with Post-Transplant Lymphoproliferative Disorder in Renal Transplant Recipients: The Israel Penn International Transplant Tumor Registry Experience American Journal Of Transplantation 2005; 5: 775-780

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.